ask="16.85"
ask_size="100"
average_daily_volume="159034"
bid="N/A"
bid_size="N/A"
book_value="-91.82"
change="-0.19"
change_from_200_day_moving_average="1.91"
change_from_50_day_moving_average="1.17"
change_from_52_week_high="-0.72"
change_From_52_week_low="3.88"
change_in_percent="-1.18%"
close="15.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="16.11"
high_52_weeks="16.65"
last_trade_date="1/27/2017"
last_trade_price="15.93"
last_trade_size="2085"
last_trade_time="4:00pm"
low="15.53"
low_52_weeks="12.05"
market_capitalization="359.16M"
moving_average_200_day="14.02"
moving_average_50_day="14.76"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="15.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.66%"
percent_change_from_50_day_moving_average="+7.91%"
percent_change_from_52_week_high="-4.32%"
percent_change_from_52_week_low="+32.19%"
previous_close="16.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="63.22"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="2.66"
stock_exchange="NGM"
symbol="RARX"
volume="7549"
weeks_range_52="12.05 - 16.65"
